CLPTM1 Recombinant Antibody

Product Specifications

Background

Involved in GABAergic but not glutamatergic transmission. Binds and traps GABAA receptors in the endoplasmic reticulum (ER) . Modulates postsynaptic GABAergic transmission, and therefore inhibitory neurotransmission, by reducing the plasma membrane expression of these receptors. Altered GABAergic signaling is one among many causes of cleft palate.

Synonyms

HS9; N14.

Gene ID

1209

Swiss Prot

O96005

Host

Rabbit

Cross Reactivity

Human

Target

CLPTM1

Clonality

Recombinant

Conjugation

Unconjugated

Source

KLH conjugated synthetic peptide derived from human Putative lipid scramblase CLPTM1

Applications

WB, IHC-P, IHC-F, IF, Flow-Cyt, ICC/IF

Purification

Purified by Protein A.

Concentration

Lot dependent

Dilution

WB (1:300-5000), IHC-P (1:200-400), IHC-F (1:100-500), IF (), Flow-Cyt (1ug/Test), ICC/IF (1:50-100)

Buffer

0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol

Modification

Unmodified

Storage Conditions

Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles.

Gene ID URL

1209

Isotype

IgG

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

RC207781L3V 200 µL

OSCP (ITGBL1) (NM_004791) Human Tagged ORF Clone Lentiviral Particle

Ask

View Details

abx104275-01 100 µL

Farnesyl Diphosphate Farnesyltransferase 1 (FDFT1) Antibody

Ask

View Details

abx104275-02 200 µL

Farnesyl Diphosphate Farnesyltransferase 1 (FDFT1) Antibody

Ask

View Details

abx104275-03 1 mL

Farnesyl Diphosphate Farnesyltransferase 1 (FDFT1) Antibody

Ask

View Details

NBP2-90422CL1 0.1 mL

Rabbit Monoclonal IL-1 beta/IL-1F2 Antibody (001) [CoraFluor 1]

Ask

View Details